11 results for author:"Ugolini C." in Literature citations
Results Customize
› Repeat search in UniProtKB (1)
| The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. Elisei R., Viola D., Torregrossa L., Giannini R., Romei C., Ugolini C., Molinaro E., Agate L., Biagini A., Lupi C. et al. J. Clin. Endocrinol. Metab. 97:4390-4398(2012) · Mapped (3) |
| FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. Bellelli R., Castellone M.D., Garcia-Rostan G., Ugolini C., Nucera C., Sadow P.M., Nappi T.C., Salerno P., Cantisani M.C., Basolo F. et al. Endocr. Relat. Cancer 19:695-710(2012) · Mapped (3) |
| Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters. Proietti A., Ugolini C., Melillo R.M., Crisman G., Elisei R., Santoro M., Minuto M., Vitti P., Miccoli P., Basolo F. Thyroid 21:1209-1215(2011) · Mapped (5) |
| BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features. Proietti A., Giannini R., Ugolini C., Miccoli M., Fontanini G., Di Coscio G., Romani R., Berti P., Miccoli P., Basolo F. Thyroid 20:1263-1270(2010) · Mapped (3) |
| Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma. De Falco V., Giannini R., Tamburrino A., Ugolini C., Lupi C., Puxeddu E., Santoro M., Basolo F. J. Clin. Endocrinol. Metab. 93:4398-4402(2008) · Mapped (3) |
| BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. Elisei R., Ugolini C., Viola D., Lupi C., Biagini A., Giannini R., Romei C., Miccoli P., Pinchera A., Basolo F. J. Clin. Endocrinol. Metab. 93:3943-3949(2008) · Mapped (3) |
| A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. Salvatore G., Nappi T.C., Salerno P., Jiang Y., Garbi C., Ugolini C., Miccoli P., Basolo F., Castellone M.D., Cirafici A.M. et al. Cancer Res. 67:10148-10158(2007) · UniProtKB (1) |
| Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. Lupi C., Giannini R., Ugolini C., Proietti A., Berti P., Minuto M., Materazzi G., Elisei R., Santoro M., Miccoli P. et al. J. Clin. Endocrinol. Metab. 92:4085-4090(2007) · Mapped (3) |
| Presence of BRAF V600E in very early stages of papillary thyroid carcinoma. Ugolini C., Giannini R., Lupi C., Salvatore G., Miccoli P., Proietti A., Elisei R., Santoro M., Basolo F. Thyroid 17:381-388(2007) · Mapped (3) |
| The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma. Giannini R., Ugolini C., Lupi C., Proietti A., Elisei R., Salvatore G., Berti P., Materazzi G., Miccoli P., Santoro M. et al. J. Clin. Endocrinol. Metab. 92:3511-3516(2007) · Mapped (3) |
| Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens. Giannini R., Faviana P., Cavinato T., Elisei R., Pacini F., Berti P., Fontanini G., Ugolini C., Camacci T., De Ieso K. et al. Thyroid 13:765-770(2003) · Mapped (9) |